| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 05/31/2001 | WO2000042071A3 Compounds and methods to inhibit or augment an inflammatory response |
| 05/31/2001 | WO2000032772A3 Erythropoietic compounds |
| 05/31/2001 | WO2000015758A3 Plant resistance to insect pests mediated by viral proteins |
| 05/31/2001 | WO2000012735A3 Transgene assay using stable agrobacterium rhizogenes transformation |
| 05/31/2001 | WO2000002524A3 Botulinum neurotoxin vaccine |
| 05/31/2001 | WO2000000617A3 Ebola virion proteins expressed from venezuelan equine encephalitis (vee) virus replicons |
| 05/31/2001 | WO1999060124A3 Differentiation-associated sequences and methods of use therefor |
| 05/31/2001 | WO1999028462A9 Polypeptides and nucleic acids encoding the same |
| 05/31/2001 | WO1999028341A9 Maintenance of smooth muscle integrity by morphogenic proteins |
| 05/31/2001 | WO1999024553A9 X-ray crystal comprising hiv-1 gp120 |
| 05/31/2001 | WO1999006554B1 5' ESTs FOR SECRETED PROTEINS EXPRESSED IN MUSCLE AND OTHER MESODERMAL TISSUES |
| 05/31/2001 | US20010002490 Method of increasing growth and yield in plants |
| 05/31/2001 | US20010002420 Nucleic acid markers for rice blast resistance genes and rice blast resistance genes isolated by the use of these markers |
| 05/31/2001 | US20010002419 Homogeneous preparation of protein, e.g. leptin, modified at the N-terminal only by an anhydride, e.g. succinic anhydride, ethylenediaminetetraacetic dianhydride; improved solubility; no inflammation at injection sites |
| 05/31/2001 | US20010002400 Administering an antifungal agent |
| 05/31/2001 | US20010002392 Administrated an effective amount of cartilage oligomeric matrix protein(COMP) to prevent or treat the rheumatoid arthritic condition of a mamal |
| 05/31/2001 | US20010002311 Treponema pallidum fused antigen and assay for anti-treponema pallidum antibodies using the same fused antigen |
| 05/31/2001 | US20010002263 Complex of human growth hormone and zinc and use |
| 05/31/2001 | DE19954444A1 Verfahren zum Schutz von Säugetierzellen mittels überexprimierter G-2/M-Zellzykluskoppler A method of protecting mammalian cells by means of overexpressed G-2 / M-Zellzykluskoppler |
| 05/31/2001 | DE19953979A1 Recovering beta-lactoglobulin from whey protein hydrolyzate comprising enzymatic hydrolysis performed during ultrafiltration, increases the yield of the food additive |
| 05/31/2001 | DE10056747A1 New nucleic acid sequences from a human immune deficiency virus intersubtype, useful for treatment, prevention and diagnosis of infection |
| 05/31/2001 | CA2394914A1 A novel method of diagnosing, monitoring, staging, imaging and treating cancer |
| 05/31/2001 | CA2393126A1 Isolation of five novel genes coding for new fc receptors-type melanoma involved in the pathogenesis of lymphoma/melanoma |
| 05/31/2001 | CA2392649A1 Assay of isomerised and/or optically inverted proteins |
| 05/31/2001 | CA2392639A1 G-protein coupled receptor htogh35 |
| 05/31/2001 | CA2392527A1 Hbv/hcv virus-like particle |
| 05/31/2001 | CA2392495A1 Reagents and methods for identifying and modulating expression of genes regulated by cdk inhibitors |
| 05/31/2001 | CA2392490A1 Polypeptides comprising multimers of nuclear localization signals or of protein transduction domains and their use for transferring molecules into cells |
| 05/31/2001 | CA2392475A1 Moss genes from physcomitrella patens coding proteins involved in the synthesis of polyunsaturated fatty acids and lipids |
| 05/31/2001 | CA2392472A1 Use of disease-associated gene |
| 05/31/2001 | CA2392468A1 Gene therapy of hiv-positive patients by the expression of membrane-anchored gp41 peptides |
| 05/31/2001 | CA2392456A1 Assays and therapies for latent viral infection |
| 05/31/2001 | CA2392387A1 Polypeptides and methods for thymic vaccination |
| 05/31/2001 | CA2392366A1 Major intrinsic protein (mip)-like polynucleotides, polypeptides, and antibodies |
| 05/31/2001 | CA2392355A1 Oxidized apolipoproteins and methods of use |
| 05/31/2001 | CA2392351A1 Novel transcription factor and dna thereof |
| 05/31/2001 | CA2392272A1 Modified adenovirus fibre and uses |
| 05/31/2001 | CA2392235A1 Membrane virus host range mutations and their uses as vaccine substrates |
| 05/31/2001 | CA2392175A1 A conjugate of a collagen ii-binding fragment and an arthritis-affecting pharmaceutical substance |
| 05/31/2001 | CA2392019A1 Method of forming a peptide-receptor complex with zsig33 |
| 05/31/2001 | CA2392015A1 Method of separating prions from biological materials |
| 05/31/2001 | CA2391991A1 Method for lowering pollen fertility by using pollen-specific zinc finger transcriptional factor genes |
| 05/31/2001 | CA2391943A1 Cell permeable peptides for inhibition of inflammatory reactions and methods of use |
| 05/31/2001 | CA2391386A1 Peptides having antiangiogenic activity |
| 05/31/2001 | CA2391156A1 Method for reducing pollen fertility using tapetum-specific zinc finger transcription factor gene |
| 05/31/2001 | CA2390802A1 A novel method of diagnosing, monitoring, staging, imaging and treating breast cancer |
| 05/31/2001 | CA2390767A1 Nontoxic vernix compositions and method of producing |
| 05/31/2001 | CA2390465A1 Kunitz-type protease inhibitor polynucleotides, polypeptides, and antibodies |
| 05/31/2001 | CA2390344A1 85kda neisserial antigen |
| 05/31/2001 | CA2390078A1 G protein-coupled receptor-like receptors and modulators thereof |
| 05/31/2001 | CA2386893A1 N-alkylated peptides having antiangiogenic activity |
| 05/31/2001 | CA2370322A1 Novel peptide dimers as agonists of the erythropoietin (epo) receptor, and associated methods of synthesis and use |
| 05/31/2001 | CA2366230A1 Primary nucleotide sequence of the shrimp white spot bacilliform virus (wsbv), discovery systems containing this sequence and detection kits and antiviral targets for detection and controlling shrimp virus outbreak and spread |
| 05/30/2001 | EP1103623A1 Human mucin core protein: nucleic acid probes, peptide fragments and antibodies thereto, and uses thereof in diagnostic and therapeutic methods |
| 05/30/2001 | EP1103616A2 Synthetic plant genes and method for preparation |
| 05/30/2001 | EP1103614A1 Novel plasmid vector |
| 05/30/2001 | EP1103610A1 Production of vaccines from immortalised mammalian cell lines |
| 05/30/2001 | EP1103609A1 Differentiation regulatory factor expressed specifically in testis |
| 05/30/2001 | EP1103608A1 CIDE-like protein, its isolation and uses |
| 05/30/2001 | EP1103606A2 Methods for generating polynucleotides having desired characteristics by iterative selection and recombination |
| 05/30/2001 | EP1103564A1 Cancer antigens based on tumor suppressor gene wt1 product |
| 05/30/2001 | EP1103563A1 Novel g protein-conjugated receptor protein and dna thereof |
| 05/30/2001 | EP1103562A1 Novel g-protein coupled receptor protein and dna thereof |
| 05/30/2001 | EP1103561A1 Hla-a2 restraint tumor antigen peptide originating in sart-1 |
| 05/30/2001 | EP1103268A1 Use of staphylococcal enterotoxins or related compounds for cancer treatment by infusion |
| 05/30/2001 | EP1102992A1 Reporter gene system for use in cell-based assessment of inhibitors of the hepatitis c virus protease |
| 05/30/2001 | EP1102977A1 Fluorescence assay for biological systems |
| 05/30/2001 | EP1102976A1 Multiple frequency fluorescence lifetime imaging |
| 05/30/2001 | EP1102863A1 Mutations in and genomic structure of herg - a long qt syndrome gene |
| 05/30/2001 | EP1102850A1 Regions of papilloma virus e1 helicase involved in e1 oligomerization |
| 05/30/2001 | EP1102849A2 A plant disease resistance signalling gene: materials and methods relating thereto |
| 05/30/2001 | EP1102848A2 Molecules designated ldcam |
| 05/30/2001 | EP1102847A2 Novel tension-dependent potassium channel and the use thereof in the development of new therapeutic agents |
| 05/30/2001 | EP1102846A1 Pancreatic and ovarian polypeptide, zsig58 |
| 05/30/2001 | EP1102845A1 Calcium/calmodulin dependent kinase and an alternative splice product thereof |
| 05/30/2001 | EP1102844A2 Human neuronal acid-sensitive cationic channel, its cloning and applications |
| 05/30/2001 | EP1102843A1 Nucleic sequences coding for an at2 interacting protein interacting with the at2 receptor and their applications |
| 05/30/2001 | EP1102841A2 Method for selective and optionally reversible degeneration of somatic plant tissue |
| 05/30/2001 | EP1102840A2 Transgenic animals having a modified glycoprotein v gene |
| 05/30/2001 | EP1102838A2 A method of modulating the efficiency of translation termination and degradation of aberrant mrna involving a surveillance complex comprising human upf1p, eucaryotic release factor 1 and eucaryotic release factor 3 |
| 05/30/2001 | EP1102791A1 Modified green fluorescent protein |
| 05/30/2001 | EP1102790A2 Immunological herpes simplex virus antigens and methods for use thereof |
| 05/30/2001 | EP1102788A2 Prevention and treatment of viral disease |
| 05/30/2001 | EP1102596A1 Peptide antagonists of zonulin and methods for use of the same |
| 05/30/2001 | EP1102530A1 Use of an animal model deficient in p53 and having memory deficiency and/or behavioural disorders for therapeutic purposes |
| 05/30/2001 | EP1102528A1 Translation control elements for high-level protein expression in the plastids of higher plants and methods of use thereof |
| 05/30/2001 | EP0859785B1 Cyclic peptide analogs of somatostatin |
| 05/30/2001 | EP0730607B1 Novel integrin-binding peptides |
| 05/30/2001 | EP0721586B1 Methods and compositions for treatment of bcr-abl associated leukemias and other cell proliferative disorders |
| 05/30/2001 | EP0721468B1 Platelet aggregation inhibitory peptides |
| 05/30/2001 | EP0662093B1 Hiv immunotherapeutics |
| 05/30/2001 | EP0621788B1 Hemoregulatory peptides |
| 05/30/2001 | CN1297532A Identification of chemical active agents for inhibiting 1-desoxy-D-xylulose-5-phosphate biosynthetic pathway in parasites, and said active agents |
| 05/30/2001 | CN1297531A Isolated nucleic acid molecule encoding cancer associated antigens, antigens per se, and uses thereof |
| 05/30/2001 | CN1297486A Anti-viral vectors |
| 05/30/2001 | CN1297485A i (streptomyces avermitilis) gene directing ratio of B2:B1 avermectins |
| 05/30/2001 | CN1297482A Group B streptococcus antigens |
| 05/30/2001 | CN1297454A Novel omega-conotoxin peptides |
| 05/30/2001 | CN1297452A Modified factor VIII |
| 05/30/2001 | CN1297047A Polypeptide-human protein phosphatase 1 regulatory protein 68 and polynucleotide for coding said polypeptide |